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Summary
Aneural muscle cells in culture often form acetylcholine
receptor (AChR) clusters, termed hot spots, which are
similar to those found at the postsynaptic membrane
both in structure and in molecular composition.
Although hot spots form on both dorsal and ventral
surfaces of the cell, the ventral ones are better
characterized because of their association with sites of
cell-substratum contact. To understand the stimuli and
mechanisms involved in ventral hot spot formation,
native, uncoated polystyrene beads were applied to
cultured Xenopus myotomal muscle cells to create local
membrane-substratum contacts. These beads were able
to induce a postsynaptic-type development as evidenced
by the clustering of AChRs and the development of a set
of ultrastructural specializations, including membrane
infoldings and a basement membrane. Whereas these
native beads were effective in inducing clustering, beads
coated with bovine serum albumin or treated with
serum-containing medium were ineffective. Native
beads were also capable of inducing clusters in serum-
free medium, indicating that their effect was mediated
by endogenous molecules that were locally presented by
the beads, rather than by bead adsorption of com-
ponents in the medium. Heparan sulfate proteoglycan
(HSPG) is a major component of the muscle extracellu-
lar matrix and our previous study has shown that basic
fibroblast growth factor (bFGF), a member of the
heparin-binding growth factor (HBGF) family, and its
receptor are present in Xenopus myotomal muscle
during the period of synaptogenesis. Therefore, we
tested the involvement of HBGF in bead induction. The
results of this study show the following: (1) preincu-
bation of cultures in heparin, which solubilizes matrix-
bound HBGFs, suppressed the bead-induced AChR
clustering. (2) Suramin, which interferes with the
interaction between several growth factors and their
receptors, also inhibited bead-induced clustering.
(3) Tyrphostin, which blocks tyrosine kinase activity
associated with a number of growth factor receptors, was
also inhibitory to the bead effect. (4) The percentage of
bead-induced AChR clusters was significantly enhanced by
pretreating the cultures with bFGF prior to bead
application. This exogenously applied bFGF could be
largely removed by treatment of cultures with heparin,
suggesting its association with HSPG at the cell surface.
(5) An anti-bFGF neutralizing antiserum significantly
reduced the efficacy of the bead stimulation. These data
suggest that uncoated beads, which adhere to the cell
surface and can mimic the cell-substratum interaction,
effect a local presentation of HBGFs, such as bFGF,
residing with the HSPG to their membrane receptors,
thereby locally activating receptor-associated tyrosine
kinases. This may be followed by tyrosine phosphorylation
of yet unidentified substrate proteins, resulting in cluster-
ing of AChRs. We propose that a similar local presentation
of HBGF may also underlie the postsynaptic induction at
developing neuromuscular junctions.
Key words: ACh receptor, neuromuscular junction,
heparin-binding growth factor.
Introduction
Tissue culture of nerve and muscle cells offers a
convenient system for studying synaptogenesis. When
processes from motoneurons come into contact with
muscle cells in culture, functional neuromuscular
junctions (NMJs) develop. These in vitro junctions
acquire a considerable degree of specialization as
evidenced by the clustering of acetylcholine receptors
(AChRs) in the postsynaptic membrane, the accumu-
lation of acetylcholinesterase in the synaptic cleft and
the development of synaptic vesicle clusters in the nerve
terminal (Bloch and Pumplin, 1988; Peng, 1987). It is
generally thought that the signal for postsynaptic
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differentiation comes from the motoneuron. In the
absence of innervation, however, AChR clustering still
occurs (Anderson et al. 1977; Fischbach and Cohen,
1973; Sytkowski et al. 1973; Bloch and Pumplin, 1988).
Aneural clusters, commonly called hot spots, bear a
striking resemblance to the postsynaptic membrane in
innervated cells both in structure and in molecular
composition. Although hot spots can be found any-
where on the muscle cell, the most prominent ones are
displayed at sites of close cell-substratum contact
(Bloch and Pumplin, 1988). They form on substrata
coated with proteinaceous molecules, such as collagen
and polylysine, as well as on uncoated glass or plastic.
Thus, contact with the substratum alone provides the
necessary signal for the induction of AChR clustering.
Previously we showed that AChR clustering can also
be induced in cultured Xenopus muscle cells by
polycation-coated latex beads (Peng and Cheng, 1982).
These studies suggest that the local presentation of a
stimulus in the form of a mini-substratum can mimic the
action of nerve in inducing postsynaptic differentiation.
However, the nature of this stimulation is still un-
known. Recently we became interested in the role of
polypeptide growth factors in NMJ development, since
this class of molecules is universally used in the
signalling of cell differentiation and proliferation. Of
particular interest is basic fibroblast growth factor
(bFGF), an extracellular matrix (ECM)-associated
growth factor (Esch et al. 1985; Gospodarowicz et al.
1986). bFGF has a strong affinity for heparin, and for
heparan sulfate proteoglycans (HSPG), which provide
extracellular storage sites for this growth factor (Bur-
gess and Maciag, 1989; Rifkin and Moscatelli, 1989).
ECM-associated bFGF can be mobilized by surround-
ing cells to exert an autocrine or paracrine regulation on
cellular processes (Saksela and Rifkin, 1990; Rifkin and
Moscatelli, 1989). Both bFGF and HSPG are found on
the surface of developing skeletal muscle, which also
possesses receptors for bFGF (Anderson and Fam-
brough, 1983; Bayne et al. 1984; Joseph-Silverstein et
al. 1989; Seed et al. 1988; Olwin and Hauschka, 1988).
Recently we showed that bFGF-coated beads can also
induce the formation of AChR clusters (Peng et al.
1991). This suggests that bFGF and/or other heparin-
binding growth factors (HBGFs) at the cell surface may
contribute to the formation of hot spots.
To test this hypothesis, we examined the effect of
native uncoated polystyrene beads on the formation of
AChR clusters in cultured Xenopus muscle cells. Here
we report that these uncoated beads also induce AChR
clustering, through a mechanism that appears to involve
an interaction between HBGFs, their receptors and
tyrosine phosphorylation. Since exogenous bFGF,
which binds to HSPG at the cell surface, significantly
increases the efficacy of the bead-induced AChR
clustering and a neutralizing bFGF antiserum sup-
presses this process, the role of bFGF is implicated.
This work was previously presented in abstract form
(Chen et al. 1990).
Materials and methods
Materials
Human recombinant bFGF was a gift from Synergen
(Boulder, CO). The tyrphostins, RG50864 (active) and
RG50862 (inactive), were gifts from Rhone-Poulanc Rorer
Central Research (Fort Washington, PA). Polystyrene latex
microspheres were purchased from Polysciences (Warrington,
PA). The bFGF monoclonal antibody (mAb; type I) was from
Upstate Biotechnology, Inc. (Lake Placid, NY). Tetramethyl-
rhodamine or FITC-conjugated a--bungarotoxin (R-BTX or
F1TC-BTX) were purchased from Molecular Probes, Inc.
(Eugene, OR). BSA, heparin and chondroitin sulfate A were
from Sigma Chemical Co. (St. Louis, MO). Suramin was
purchased from FBA Pharmaceuticals (New York, NY).
Fluorescent goat anti-mouse secondary antibody was from
Organon Technika (Durham, NC). Anti-bFGF neutralizing
antiserum (77R) was a generous gift from Dr. M. Klagsbrun
(The Children's Hospital, Boston, MA). A second polyclonal
anti-bFGF antibody from American Diagnostica (Greenwich,
CT) was also used for blocking experiments. Sheep anti-
rabbit IgG antiserum was also purchased from Organon-
Teknika (cat. no. 55603).
Preparation of muscle and nerve cultures
Muscle cultures were prepared according to a previously
published protocol (Peng and Nakajima, 1978). Stage 20-22
Xenopus embryos were freed from the surrounding jelly coat
and vitelline membrane, and the dorsal, myotomal portion
was dissected away and dissociated using a calcium- and
magnesium-free Steinberg solution (60 mM NaCl, 0.7 mM
KC1, 0.4 mM EDTA, 10 mM HEPES, pH 7.4). Muscle cells
were plated onto glass coverslips and grown in a culture
medium composed of Steinberg solution (60 mM NaCl, 0.7
mM KC1, 0.4 mM Ca(NO3)2, 0.8 mM MgSO4, and 10 mM
HEPES, pH 7.4) supplemented with 10% L-15 medium, 1%
fetal bovine serum, and 0.1 mg/ml gentamycin. Cultures were
maintained at 15°C or at 22°C, and were routinely used within
2-7 days after plating.
Preparation and application of polystyrene beads
Polystyrene latex beads (5 to 10 /im in diameter) were washed
for 30 min in 95% ethanol, and rinsed three times in distilled
water. They were then immediately applied to cultures or
stored in PBS at 4°C. These beads were not exposed to any
proteinaceous molecules (uncoated). The effect of masking
the bead surface by coating them with BSA or serum proteins
was also examined in this study. To coat beads with bovine
serum albumin (BSA), they were treated with PBS containing
BSA at various concentrations for 0.5-1 h after the ethanol
wash and then rinsed three times with PBS. To coat beads
with serum proteins, the ethanol-washed beads were treated
with culture medium that contained 1% fetal bovine serum for
0.5-1 h.
Beads were applied to muscle cells via micropipette. To
prevent uncoated beads from being coated by serum, the
medium level over the cells was kept at a minimum during the
bead application. The beads were allowed to associate with
the cells for a brief period (approximately 10-50 s), and then
excess, nonadhered beads were rinsed away with culture
medium. Bead-seeded cultures were incubated for 1-30 h at
22°C, and then were labeled with 0.3 fM R-BTX for 30 min.
Cells were fixed for 3 min in 95% ethanol at -20°C and
visualized with fluorescence microscopy. The effect of bead-
induced AChR clustering was quantified by scoring the
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percentage of bead-muscle contacts associated with fluor-
escent BTX labeling. This was calculated for each cell and
then the mean and standard error of the percentages from all
cells in a culture were calculated. These values are presented
in the figures. The cells were chosen at random.
Visualization of bFGF by immunofluorescence
microscopy
Immunofluorescence studies were conducted to visualize
bFGF bound to the cell surface in untreated and in bFGF-
treated cultures. First, the cultures were treated with a mAb
against bFGF for 30 min at a concentration of 50 nM, followed
by extensive washing, and labeled with rhodamine or FITC-
conjugated goat anti-mouse IgG for 30 min. The cultures were
then fixed with 95% ethanol at —20°C for 3 min and examined
under a fluorescence microscope. In some experiments,
cultures were double-labeled with FJTC-BTX and the bFGF
antibody followed by rhodamine-conjugated secondary anti-
body.
Confocal microscopy, using a Biorad MRC-600 laser
scanner and a Nikon inverted microscope, was also conducted
on these specimens. The cells were optically sectioned at 0.5-1
,um increments and stereo images were constructed with the
Biorad software.
Electron microscopy
Muscle cells were cultured in Lux Permanox tissue culture
dishes (Nunc, Naperville, IL). After incubation with beads
for 24 h, they were fixed with 1% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.2), postfixed with 1% OsO4, en bloc
stained with 1% uranyl acetate in 0.1 M acetate buffer (pH
5.5), dehydrated through an ethanol series, and embedded in
epoxy resin. Bead-bearing cells were scored with a Leitz
diamond marker on a microscope and sawed off the block.
Ultrathin sections were cut on a microtome with a diamond
knife. They were poststained with uranyl acetate and lead
citrate and examined with a JEOL 200CX transmission
electron microscope.
Drug application
Suramin was dissolved in Steinberg solution to make a 10 mM
stock solution. The stock solution was filter-sterilized and
final concentrations were prepared in Steinberg culture
medium by serial dilution. Muscle cell cultures were incu-
bated in medium containing suramin for the duration of the
experiment.
The tyrphostins RG50864 (active) and RG50862 (inactive)
were dissolved in dimethylsulfoxide (DMSO) to make a 40
mM stock solution. This solution was divided into aliquots
and stored at —80°C. Before each experiment, working
solutions were prepared in Steinberg medium by serial
dilution. Cultures were preincubated in tyrphostins for 7 h.
After the addition of beads, the cultures were maintained in
the presence of the tyrphostins for 12 h, labeled with R-BTX
and fixed. In addition to comparing the effect of the active and
the inactive tyrphostins, we also examined the effect of 0.2%
DMSO (corresponding to the highest concentration used in
the experimental groups) on bead-induced AChR clustering
and found that DMSO had no effect at this concentration.
Results
Induction of AChR clustering by uncoated beads
Clean polystyrene latex beads attached readily to
cultured Xenopus cells. After an incubation period of
24 h, clusters of AChRs, as shown by bright fluorescent
staining of R-BTX, were observed at the bead-muscle
contacts (Fig. la-b). These clusters developed discre-
tely at bead-muscle contacts and their size was
proportional to the size of the beads applied. Although
most muscle cells already had hot spots on their surface
before the addition of beads, the bead-associated
clusters arise as a result of de novo assembly and not
due to attachment of beads to preexisting hot spots for
the following reasons: (1) beads seldom landed on pre-
existing clusters as shown by the lack of R-BTX staining
at contact sites immediately after the addition of beads.
(2) Beads came into contact only with the top surface of
the cell whereas most hot spots were present on the
bottom surface. Similar to results of a previous study
(Peng, 1986), we also found that hot spots disappear
with time on cells exhibiting bead-induced clusters.
On average, 70% of bead-muscle contacts developed
AChR clusters. When the bead-muscle contacts were
examined by electron microscopy, a highly specialized
membrane area was revealed. First, beads came into
close contact with the muscle cell membrane, leaving a
cleft distance of less than 30 nm at the narrowest point
of contact (Fig. lc). The membrane apposing the bead
showed a thickening of the plasmalemma and its
associated cortical cytoplasm and was overlain with
patches of basal lamina. In addition, the membrane was
deeply invaginated (Fig. lc). These features are all
characteristic of the postsynaptic membrane at the
NMJ.
AChR clusters could be detected by R-BTX labeling
within the first hour of bead application, and the
number of clusters reached a plateau after 7-8 h of
incubation. Afterward, there was an increase in
fluorescence intensity without an increase in number
during the first 24 h. Thus, the mechanism for clustering
AChRs is set up within the first hour of bead-muscle
contact and the recruitment of receptors to the contact
site continues at least through the first 24 h.
Proteins adsorb readily to clean polystyrene surfaces.
To examine whether this property was responsible for
the induction of AChR clustering, the free bead surface
was masked with culture medium containing 1% fetal
bovine serum, or with BSA. After beads were incu-
bated for 30 min in serum-containing medium and
applied to cells, they were found to be ineffective in
inducing AChR clustering. The same effect was ob-
served after the beads were incubated with BSA (Fig.
2). Beads coated with more than 100 ^g/ml BSA were
unable to induce clustering. BSA-coated beads were
less adherent to the cells than uncoated beads as shown
by a decrease in the mean number of beads remaining
attached to cells after the cultures were rinsed immedi-
ately after bead application. However, remaining beads
still became firmly anchored to the cell surface with
time. Electron micrographs of these ineffective bead-
muscle contacts revealed that the cleft distance was still
narrow, ranging from 30 to 50 nm. However, no
ultrastructural specializations were detected at these
bead-muscle contacts (data not shown; cf. Fig. 6 of
Peng et al. 1991). These studies suggest that the AChR
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Fig. 1. AChR clusters induced
by uncoated polystyrene beads.
9 )jm beads were used in this
study, (a) Fluorescence
micrographs showing R-BTX-
labeled AChR clusters that are
located at bead-muscle
contacts as shown in the
phase-contrast micrograph in
(b). The numbers point to the
correspondence in the
positions of the AChR clusters
and the beads, (c) Electron
micrograph of ultrastructural
specializations induced by an
uncoated bead. Black
arrowheads point to basal
lamina accumulation. Open
white arrowheads point to
membrane infoldings. Filled
white arrows point to
membrane densities indicative
of sites of AChR
concentration. B, bead.
cluster-inducing capability of uncoated beads is not
simply due to a mechanical deformation of the
membrane at the bead-muscle contacts. We also
conducted experiments in Steinberg solution alone,
without added serum or L-15 medium. Under this
condition, beads were still effective in inducing AChR
clustering (data not shown). Thus, this effect is not
mediated by factors in the culture medium that bind to
the beads. Rather, factors that are localized at the cell
surface may be responsible for cluster formation. These
factors may pre-exist on the cell surface, secreted by the
cells themselves during bead-muscle contact, or derived
from the culture medium.
We also experimented with beads coated with other
molecules. As reported previously (Peng et al. 1991),
beads coated with polycations or with bFGF are very
effective in inducing AChR clustering. However, beads
coated with other basic molecules, such as cytochrome c
or the active (fi) subunit of nerve growth factor, were
ineffective. Beads coated with nonspecific immuno-
globulins, laminin or tenascin were similarly ineffective.
All of these coated beads adhered tightly to the cell
surface, suggesting that the adhesion alone is not
sufficient to trigger the clustering process.
Inhibition of AChR clustering by heparin and suramin
Previous studies have shown the existence of HSPG at
the surface of Xenopus muscle cells (Anderson and
101 10J 10*
BSA concentration (|ig/ml)
Fig. 2. Inhibition of uncoated bead-induced AChR
clustering by masking the bare bead surface with BSA.
Beads were treated with BSA solution for 30 min before
addition to the cells. The percentage of beads associated
with AChR clusters showed a decline when the BSA
concentration reached 0.1 ^g/ml. AChR clustering at the
beads was abolished when the BSA concentration reached
100 /ig/ml. 20 cells, each with 1-20 bead-muscle contacts,
were scored for each data point. Each point represents the
mean±s.e.m.
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Fambrough, 1983; Anderson, 1986; Swenarchuk et al.
1990). To test the hypothesis that the bead-induced
AChR clustering is mediated by factors bound to the
HSPG at the cell surface, the effect of heparin was
studied. Heparin has been used to solubilize HSPG-
bound growth factors away from the cell surface,
effectively preventing interaction with receptors (Flau-
menhaft et al. 1990). Cultures were preincubated with
medium containing heparin (MT 4,000-6,000) for 6 h
before bead application, and after an additional 18 h of
bead-muscle coculture in heparin-containing medium,
assayed for AChR clustering. As shown in Fig. 3,
heparin, at a concentration of 0.5 mg/ml, inhibited the
cluster formation by 60% of the control value. Lower
concentrations of heparin were ineffective, and prein-
cubation was necessary for inhibition. Chondroitin
sulfate, another glycosaminoglycan (GAG) with a
different disaccharide repeat, was ineffective in reduc-
ing the bead-induced AChR clustering (Fig. 3).
Previous studies have shown that suramin, a poly-
anionic compound with an MT of 1,429, interferes with
the interaction between certain growth factors, includ-
ing bFGF, with their receptors, thus preventing recep-
tor activation (Betsholtz et al. 1986; Fleming et al. 1989;
Coffey et al. 1987; Huang and Huang, 1988). Recent
studies on the structure of bFGF have shown that its
receptor-binding domain is distinct from its heparin-
binding domain, and it has been suggested that suramin
may interact with the receptor-binding region of bFGF
(Eriksson et al. 1991; Zhang et al. 1991). In a previous
study, we showed that suramin inhibits the formation of
AChR clusters by bFGF-coated beads (Peng et al.
1991). Therefore, we tested the effect of this compound
on AChR clustering induced by uncoated beads in this
study. As shown in Fig. 4, suramin was very effective in
inhibiting cluster formation, with a half-maximal inhi-
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Fig. 3. Effect of glycosaminoglycans on bead-induced
AChR clustering. Cultures were treated with heparin or
chondroitin sulfate for 1 h and then seeded with uncoated
beads. AChR cluster formation is suppressed by the
heparin treatment by not by the chondroitin sulfate
treatment. 20 cells were scored for each glycosaminoglycan
concentration.
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Fig. 4. Inhibition of AChR clustering by suramin. A 40
min preincubation of the cultures in suramin followed by
seeding with uncoated beads in the continued presence of
suramin resulted in a half-maximal inhibition at 35 ,aM,
and complete inhibition at 80 [tM. 20 cells were scored for
each data point.
fiM. Unlike heparin, a long preincubation period was
not necessary for the inhibitory effect of suramin. In the
presence of this compound, muscle cells maintained
normal membrane potential and ACh sensitivity as
shown by electrophysiological recording (Z. Dai and
H.B. Peng, unpublished data). Furthermore, returning
the culture to normal medium after treatment with
suramin resulted in complete reversal of this inhibition.
Thus, it appears that this effect is not due to nonspecific
cell injury. As an additional control, we preincubated
beads with suramin and washed them with distilled
water, and found they were just as effective in inducing
AChR clustering as untreated beads. Unlike protein-
aceous molecules, suramin probably does not adhere to
the beads.
Effect of a tyrosine kinase inhibitor
Since the receptors for many peptide growth factors are
tyrosine kinases, we were interested in the involvement
of tyrosine phosphorylation in the induction of AChR
clustering by uncoated beads. This was tested by using a
tyrosine kinase inhibitor, RG50864. This compound
inhibits receptor tyrosine phosphorylation and mitoge-
nesis stimulated by several growth factors in cell culture
(Lyall et al. 1989; Levitzki and Gilon, 1991; Dvir et al.
1991). We previously used this compound to inhibit
bFGF bead-induced AChR clustering (Peng et al.
1991). In this study, Xenopus cultures were pre-
incubated with tyrphostin RG50864 for 7 h before bead
stimulation and maintained in its presence after bead
addition to block tyrosine kinase activity. As shown in
Fig. 5, AChR clustering was reduced to half of the
control value at a concentration of 40 /JM, and
completely inhibited at 80 (iM. In contrast, 80 fiM
RG50862, an ineffective tyrphostin, failed to inhibit
AChR clustering when applied in the same manner
(data not shown). The inhibitory effect of RG50864 was
reversible. When beads were added to cells in normal




Fig. 5. Inhibition of AChR clustering by a tyrphostin,
RG50864. Preincubation of cultures in tyrphostin for 7 h,
followed by addition of uncoated beads in the continued
presence of the drug resulted in half-maximal inhibition at
approximately 40 /xM. Complete inhibition of AChR
clustering was observed at 80 JJM. 20 cells were scored for
each data point.
medium after a 7 h tyrphostin pre-incubation, AChR
clustering returned to 90% of the control value.
Although cells showed the formation of vacuolar
structures at higher concentrations, they were still
viable after prolonged incubation (24 h) as shown by
trypan blue exclusion (Peng et al. 1991).
Immunocytochemical localization of bFGF on
cultured muscle cells
The presence of bFGF and its receptor has been
demonstrated in the muscle tissue of Xenopus embryos
at stages during which synaptogenesis occurs by
Western blot analysis in previous studies (Peng et al.
1991; Friesel and Dawid, 1991). In order to visualize
bFGF associated with the muscle cell surface, indirect
immunofluorescence studies were carried out with a
monoclonal antibody against bFGF. As shown in Fig.
6a-b, a non-uniform, punctate staining pattern of
endogenous bFGF on the cell surface was revealed by
this procedure. It was not, however, concentrated at
AChR clusters. The labeling was specific, as it was
abolished by omission of the primary anti-bFGF
antibody.
The level of endogenous bFGF as shown by this
method was relatively low when compared with the
apparent abundance of HSPG on the surface of these
muscle cells, as shown previously by immunofluor-
escence microscopy (Anderson, 1986; Swenarchuk et
al. 1990). This suggested that HSPGs on the cell surface
could accommodate a much higher amount of bFGF.
To study this possibility, human recombinant bFGF, at
a concentration of 1 jig/ml, was bath-applied to the
culture. After an incubation period of 1 h, the culture
was washed extensively and labeled with the anti-bFGF
antibody. This resulted in a dramatic increase in the
bFGF labeling at the surface of muscle cells. Fig. 7
shows a composite confocal stereo image through a
muscle cell treated according to this procedure. The
application of exogenous bFGF resulted in bright
staining of the cell surface. It showed that this staining is
entirely restricted to the cell surface and no intracellular
staining was observed (Fig. 7). Again, the staining was
abolished if the primary antibody was omitted.
Interestingly, not all cell types in the culture exhibited
this intensified labeling after bFGF application. For
example, melanocytes showed an absence of bFGF
labeling and fibroblasts showed a much reduced
staining as compared with muscle cells (results not
shown). Thus, muscle cells appeared to be highly
enriched in surface binding sites for bFGF.
Fig. 6. Immunolocalization of




Arrowheads point to punctate
sites of bFGF localization
revealed by labeling with an anti-
bFGF mAb and a rhodamine-
conjugated secondary antibody,
(c, d) The culture was treated
with 1 jig/ml recombinant human
bFGF for 1 h and then washed
with medium containing 0.5
mg/ml heparin for 1 h. It was
then labeled with FITC-BTX (c)
and anti-bFGF mAb followed by
rhodamine-conjugated secondary
antibody (d). The residual bFGF
was especially concentrated at
AChR clusters (white arrows).
Away from AChR clusters, bFGF
was still present in a punctate
manner (arrowheads).
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Fig. 7. Confocal stereo
micrograph of a muscle cell
treated with 1 /ig/ml recombinant
human bFGF for 1 h, followed by
immunolabeling with anti-bFGF
mAb and rhodamine secondary
antibody. This treatment
dramatically increased the amount
of bFGF on the cell surface. The
stereo image shows the exclusive
surface localization of bFGF. A
stereo viewer can be used to see
the stereo effect.
The punctate, streaky pattern of exogenous bFGF
binding on the surface of muscle cells resembles the
HSPG distribution in these cells (Anderson, 1986;
Swenarchuk et al. 1990). Previous studies have shown
that bFGF bound to HSPG can be removed by bath
application of heparin (Flaumenhaft et al. 1990). To
examine whether HSPG is the site of exogenous bFGF
binding in Xenopus muscle cells, we studied the effect
of heparin in displacing the surface-bound bFGF. We
found that incubation in medium containing heparin, at
a concentration of 10-500 /ig/ml for 1 h, removed the
bulk of the exogenously applied bFGF (Fig. 6d). This
suggests that HSPG at the cell surface can serve as a
storage site for exogenously applied bFGF. However,
even at 500 /ig/ml, heparin failed to remove bFGF
completely from the cell surface. A residual amount of
bFGF, especially at sites of AChR clusters, resisted this
treatment (Fig. 6c-d). Thus, it appears that a pool of
heparin-resistant bFGF-binding sites exists at the cell
surface. We do not think these sites are the tyrosine
kinase-type bFGF receptors, since an antibody that
recognizes the Xenopus bFGF receptors by Western
blot failed to show any localized distribution by
immunocytochemistry.
Similar experiments were also conducted with the
polyanion suramin, since it effectively blocked the
bead-induced AChR clustering. However, we found
that at 80 JJM, the concentration that completely
inhibited AChR clustering induced by beads, suramin
failed to remove the exogenously applied bFGF from
the cell surface (data not shown). This is consistent with
recent data that suramin may interfere with the
receptor-binding domain of bFGF and not with the
heparin-binding domain (Eriksson et al. 1991).
Effect of exogenous bFGF on AChR clustering
Cultures treated with uncoated beads routinely demon-
strated AChR clustering at about two thirds of the
bead-muscle contacts. This might be explained by the
sparse and uneven distribution of molecules at the cell
surface responsible for triggering AChR clustering. We
wondered whether an increase in the amount of a
HBGF at the cell surface could lead to an increase in
the efficacy of beads in inducing AChR clustering. To
test this hypothesis, we pretreated cells with recombi-
nant human bFGF for 1 h and, after washing away the
unbound growth factor, applied beads to them. This
bath application of bFGF did not result in an increase in
the number of hot spots even though some bFGF
should diffusely activate specific receptors (Peng et al.
1991).
This procedure, however, resulted in a significant
increase in the formation of AChR clusters at bead-
muscle contacts as illustrated in Fig. 8. We quantified
the percentage of beads that were associated with
AChR clusters in cultures pretreated with different
concentrations of bFGF. Pretreatment with 0.1 fJ.g/m\
bFGF did not result in significant increase in AChR
clustering (P=0.081). However, when the bFGF con-
centration was raised to 1 to 10 /ig/ml, we observed a
significant increase in clustering (P<0.001). In these
cultures, over 90% of the bead-muscle contacts
exhibited AChR clusters as compared with a mean of
70% in the control. These results suggest that exogen-
ously applied bFGF, which binds to HSPG at the cell
surface as shown in Fig. 7, can be effectively presented






Fig. 8. Quantitation of bead-induced AChR clustering in
control and bFGF-treated cultures. A dose dependence of
bFGF-mediated enhancement of AChR clustering was
observed. Pretreatment of cultures with 1 or 10 /ig/ml
bFGF resulted in a significant increase in the number of
bead-induced clusters. The P values from Student's f-test
for each bFGF sample with respect to the control are as
follows: P=0.081 at 0.1 /ig/ml, P<0.001 at 1 /ig/ml, and
P<0.001 at 10 /ig/ml.
550 L. P. Baker and others
Fig. 9. The effect of neutralizing bFGF antiserum on the
bead-induced AChR clustering. The culture was treated
with a 1:25 dilution of antiserum 77R. This treatment
abolished the bead-induced AChR clustering. However,
hot spots were still present on the muscle cell (between
arrowheads in a). Asterisks in b indicate beads.
Effect of a bFGF neutralizing antiserum on bead-
induced AChR clustering
To test further the involvement of bFGF in the
induction of AChR clustering by beads, we studied the
effect of several neutralizing antibodies to bFGF: a
sheep polyclonal antiserum generated against human
bFGF (77R, from Dr. M. Klagsbrun), a mouse mAb
against bovine brain bFGF (UBI, type I), and a Protein
A-purified polyclonal rabbit antibody generated against
human placental bFGF (American Diagnostica). Cul-
tures were preincubated in varying antibody concen-
trations for 0.5-1.0 h, and beads were applied in the
presence of the antibody. Excess beads were washed off
and the cultures were incubated overnight in the same
antibody solution. Of these antibodies, only the 77R
antiserum was able to consistently inhibit uncoated
bead-induced clustering (Fig. 9a-b). The effect of this
antiserum in blocking the action of bFGF has recently
been described in another study (Kandel et al. 1991).
The inhibitory effect of this antiserum was dose-
dependent, with a half-maximum inhibition at a
dilution of 1:50 (Fig. 10). Although the bead-induced
clustering was suppressed by this antiserum, hot spots
were still observed (Fig. 9a), showing that it did not
exert a deleterious effect on the cells. Control exper-
iments were carried out using a commercially available
unfractionated polyclonal sheep antiserum generated
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Fig. 10. Quantitation of the effect of bFGF neutralizing
antiserum 77R on bead-induced AChR clustering. The
results of two experiments were pooled. Each point
represents a mean of 50 cells. The values were normalized
to that of the control (untreated).
(1988), polyclonal antiserum contains at most 1 mg/ml
specific immunoglobulins against the injected antigen.
Thus, the blocking 77R antiserum solution contained an
estimated 40 ^g/ml immunoglobulin at the highest
concentration (1:25 dilution) used in this study. On the
basis of this calculation, we tested the control antiserum
over a concentration range of 50 to 500 /ig/ml and
applied to the culture in the same manner as the
blocking antiserum. Our results showed that this sheep
anti-rabbit antiserum failed to diminish the bead-
induced AChR clustering at all concentrations tested.
Discussion
These experiments show that clean, uncoated poly-
styrene microspheres can mimic nerve in inducing the
formation of AChR clusters and other postsynaptic
structures in cultured Xenopus muscle cells. Our results
are consistent with a recent report by Anderson et al.
(1991). In addition to the postsynaptic-type specializ-
ations documented here, their study also demonstrates
the accumulation of HSPG at sites of bead-induced
AChR clustering, similar to that seen at the NMJ. The
interaction at bead-muscle contacts resembles the cell-
substratum interaction. In both cases, the cell mem-
brane comes into close apposition with a solid surface.
It is at these sites of cell-substratum interaction that
AChR hot spots are often observed (Bloch and
Pumplin, 1988). The advantage of the bead model is
that one can precisely time the presentation of the
stimulus, and study the process of AChR clustering at
predetermined sites. Thus, this model allows a rela-
tively easy dissection of the AChR clustering process.
The beads used in this study are made of polystyrene,
which is often used as a substratum for protein
adsorption. However, one can rule out the adsorption-
mediated concentration of proteins from the culture
medium onto the bead surface as the cause of AChR
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clustering, since the same effect was observed in a salt
solution without any exogenously added proteins or
serum. Furthermore, if the bead surface is masked by
inert molecules, such as BSA or serum, the beads lose
their inductive action, even though they are still
attached to the cell surface. This suggests that a simple
mechanical perturbation of the membrane does not
activate the clustering process. A remaining possibility
is that the beads somehow utilize components at the cell
surface to stimulate the cells. These components may
be intrinsic to the cells in culture, or derived from
culture medium. In addition, endogenous factors may
pre-exist at the cell surface or be secreted during the
time of bead contact, and since the process of AChR
clustering is triggered soon after the beads come into
contact with the cell surface, we favor the former
possibility.
The possible role of a HBGF
In this study, we have concentrated on the role of
HBGF(s) at the surface of muscle cells in postsynaptic
induction for two reasons.
(1) HSPG is a prominent component of the muscle
surface (Anderson and Fambrough, 1983; Bayne et al.
1984; Anderson et al. 1984; Anderson et al. 1991).
Certain forms of this proteoglycan are present in the
ECM, whereas others exist as integral membrane
proteins, e.g. syndecan (Ruoslahti and Yamaguchi,
1991). It is not known which forms are present on
Xenopus muscle cells. However, ultrastructural studies
have shown that there is very little ECM on these
muscle cells in culture, except at AChR clusters
(Weldon and Cohen, 1979; Luther and Peng, 1985).
Thus, a major portion of the HSPG in the area away
from AChR clusters may be in membrane-bound form,
whereas both forms may be present at clusters. Recent
studies have shown that an important function of either
form of HSPG is to provide binding sites ('low-affinity
receptors') for HBGFs (Rifkin and Moscatelli, 1989;
Ruoslahti and Yamaguchi, 1991).
(2) bFGF is a member of the HBGF family. Among
members of this family, bFGF binds heparin with the
highest affinity (Burgess and Maciag, 1989). Our recent
study has shown that beads coated with bFGF can
induce the formation of AChR clusters, and by
immunoblot analysis, both bFGF and its receptor are
present in Xenopus myotomal muscle in vivo at stages
during which synaptogenesis occurs (Peng et al. 1991).
Previous studies have also shown that bFGF is present
in skeletal muscle in vivo in other species (Joseph-
Silverstein et al. 1989; Gonzalez et al. 1990; DiMario et
al. 1989). Thus, bFGF is a possible candidate for a
HSPG-bound factor available for synaptic induction.
A series of experiments were conducted in this study
to test the involvement of HBGF, in general, and
bFGF, in particular, in uncoated bead-induced AChR
clustering. First, heparin was found to be inhibitory to
the effect of beads. Recent studies have shown that
bFGF bound to an artificial matrix or to a cell
monolayer can be solubilized by heparin (Flaumenhaft
et al. 1990). Thus, this inhibitory effect on AChR
clustering may be due to the a removal of bFGF
normally bound to HSPG at the cell surface. This is also
supported by our finding that heparin treatment
removes exogenously applied bFGF. However, this
removal is incomplete even at the highest concentration
(0.5 mg/ml) used in this study. This suggests that some
bFGF may be bound to a pool of cell surface binding
sites with much higher affinity. These sites are particu-
larly concentrated at AChR hot spots (Fig. 6c-d), where
the ECM is organized into a basement membrane
(Weldon et al. 1981; Luther and Peng, 1985), suggesting
that basement membrane-bound bFGF is resistant to
heparin. The incomplete removal of exogenous bFGF
may explain the partial suppression of bead-induced
AChR clustering by heparin (Fig. 3). Previously,
Hirano and Kidokoro (1989) showed that heparin or
heparan sulfate, at concentrations similar to those used
here, causes a 50% inhibition in nerve-induced cluster-
ing in Xenopus cultures. Thus, heparin essentially
exerts the same inhibitory effect on AChR clustering
induced by beads and by nerve.
In contrast to heparin, another polyanionic com-
pound, suramin, inhibits AChR clustering completely.
With regard to bFGF, the action of suramin appears to
be directed to the receptor-binding domain, rather than
the heparin-binding domain (Eriksson et al. 1991).
Consistent with this notion is our finding that it does not
remove exogenous bFGF from the cell surface. The
action of suramin is not specific to bFGF, as it also
interferes with interactions of other growth factors with
their receptors (Betsholtz et al. 1986; Fleming et al.
1989; Coffey et al. 1987; Huang and Huang, 1988), as
well as with signalling pathways involved in embryonic
induction mediated by peptide growth factors (Gerhart
et al. 1989; Smith, 1989).
A second piece of evidence supporting the role of a
HBGF is the finding that exogenous application of
bFGF that results in a large increase in the amount of
bound bFGF to the surface of muscle cells enhances the
efficacy of the bead-induced AChR clustering. This
suggests that the failure of some beads to elicit AChR
clustering in control cultures may be due to the fact that
the endogenous HBGF level at the cell surface is
relatively low and unevenly distributed, as our immuno-
fluorescence study has suggested.
Previous studies have shown that the number of
bFGF binding sites in the form of HSPG greatly
exceeds that of the bFGF receptors and most of the
exogenously applied bFGF binds to these sites (Mosca-
telli, 1988). In fact, bath application of bFGF to
Xenopus muscle cells by itself has no effect on AChR
clustering (Peng et al. 1991), in contrast to the high
degree of cluster induction when beads are applied to
bFGF-treated cells. This suggests that the HSPG-bound
bFGF at the cell surface may be more effectively
presented to the bFGF receptor by beads. Recent
studies have suggested that complexing with heparin or
HSPG may be essential for bFGF to activate its
receptors (Rapraeger et al. 1991; Ruoslahti and Yama-
guchi, 1991; Yayon et al. 1991). Given that the beads
can elicit AChR clustering at any site on the cell
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surface, the distribution of the endogenous molecules
that can be presented by the beads to trigger this
process are likely to exist in a diffuse manner.
Consistent with this notion is our finding that endogen-
ous bFGF exists in a diffuse pattern and is not visibly
concentrated at specific sites on the cell surface, e.g. at
hot spots.
The suppression of bead-induced AChR clustering by
an anti-bFGF antiserum (77R, generated in sheep)
offers support for the involvement of bFGF in uncoated
bead effects. This antiserum apparently recognizes the
receptor-binding domain of bFGF as opposed to the
heparin-binding domain (Dr. M. Klagsbrun, personal
communication). The inhibitory effect does not appear
to be due to serum-coating of the beads, as high
concentrations (up to 500 jUg/ml) of a non-specific sheep
antiserum were not inhibitory. The reason why the
other two antibodies used in this study were not
inhibitory is not known. Both of these antibodies were
partially purified, but the epitope that they recognize is
not known. The inhibitory antiserum (77R), on the
other hand, is not purified, and the titer was relatively
low according to our dot blot analysis. However, the
inhibitory effects were clear cut. Species differences, or
differences in antibody affinity for specific epitopes may
explain these results.
These studies suggest that the stimulation presented
by uncoated beads is mediated by the presentation of
molecules bound to HSPG at the cell surface. Since the
bare polystyrene surface is sticky, one can imagine that
the beads might adsorb HSPG and its associated growth
factor molecules and at the same time make a tight
contact with the cell surface. By this action, the HBGF
is forced into contact with specific membrane receptors
and exerts a local activation. This hypothesis is shown
schematically in Fig. 11. Subsequent intracellular
amplification may eliminate the necessity for an
accumulation of extracellular signalling molecules at
the site of synaptic differentiation. Consistent with this
notion is our observation of a relatively diffuse, low
level of endogenous bFGF labelling. If the sticky bead
surface is masked by inert molecules, it can no longer
adsorb HBGF to present to receptors. This may explain
the lack of effect of beads coated with BSA, or other
small basic proteins such as cytochrome c or NGF, even
though these beads still adhere to the cell surface.
Recently, Anderson et al. (1991) showed that native,
uncoated polystyrene beads can desorb fluorescently
conjugated ECM molecules, such as laminin and
fibronectin, that are adsorbed on a solid substratum.
On the basis of this result, they proposed that the
synaptogenic activity of these beads is due to a focal
removal of certain weakly bound peripheral cell surface
components. While there is yet no experimental
evidence indicating that such a desorptive process per
se can serve as a stimulatory signal on inductive
processes, it is conceivable that molecules removed by
beads from the ECM can be focally presented to the cell
as a positive signal. This interpretation is entirely
consistent with the data presented in our current work.
Beads coated with polycations or bFGF, on the other
Fig. 11. A model depicting the role of bFGF (or some
other HBGF) in mediating the formation of synaptic
specializations induced by beads. The adhesive surface of
the bead can adsorb bFGF bound to HSPG at the cell
surface (A) and present it to cell surface receptors (B).
This local signal activates a mechanism to cluster AChRs at
the bead-muscle contact (C).
hand, can directly present effective stimuli for AChR
clustering. We think that these coated beads may
directly activate membrane receptors to signal the
initiation of the clustering process. bFGF-coated beads
presumably activate bFGF receptors. The mechanism
of activation by polycation-coated beads is unknown.
However, recent studies have suggested that polyca-
tions such as polylysine can nonspecifically activate
receptors for several growth factors, including the
bFGF receptor (Dauchel et al. 1989; Kuo et al. 1990).
Thus, the stimulation by bFGF and polycation-coated,
and by uncoated, beads may utilize a common pathway.
The ability of exogenously applied bFGF to increase
significantly bead-induced AChR clusters suggests that
bFGF is able to synergize with the endogenous stimulus
presented to the cell by the beads. The exact identity of
this endogenous signal is unknown; however, given the
results of this study, it appears that a HBGF, perhaps
bFGF itself, may be involved. The possibility remains
that other factors secreted by the cells in culture and
deposited on the cell surface, such as agrin (Nitkin et al.
1987; Fallon and Gelfman, 1989; Godfrey et al. 1988),
are similarly capable of being presented to specific cell-
surface receptors by these beads. Whatever the identity
of the endogenous molecule, the ability of its localized
presentation to initiate clustering may shed light on the
intracellular mechanisms involved in this process.
The contact and adhesion model of NMJ formation
Previously, Bloch and Pumplin proposed the 'contact
and adhesion' model to explain the formation of AChR
clusters (Bloch and Pumplin, 1988). This hypothesis
depicts that the muscle cell's contact with the sub-
stratum or between synaptic partners initiates a se-
quence of events, including the organization of an actin-
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based cytoskeleton, which leads to the clustering of
AChRs. The occurrence of AChR clusters at close cell-
substratum contacts and at bead-muscle contacts is
consistent with this model. Our study has provided a
molecular basis for understanding why this adhesive
interaction can lead to synaptic induction. In the
formation of hot spots, a simple substratum-mediated
presentation of HBGF, similar to the scheme proposed
above for the bead-muscle interaction, may be suf-
ficient to trigger the clustering process. However, a
more elaborate process has to be invoked for the nerve-
muscle interaction, since the cell-cell contact may be
fundamentally different. The finding that nerve-
induced AChR clustering can be partially inhibited by
heparin (Hirano and Kidokoro, 1989) suggests that
HBGFs may also play an important role in NMJ
development. Recent studies have shown that the
release of HBGF, in particular bFGF, from the HSPG
may involve a proteolytic step (Saksela and Rifkin,
1990). Proteases secreted by nerve growth cones, such
as plasminogen activator (Pittman et al. 1989; McGuire
and Seeds, 1990), may cleave HSPG at the developing
NMJ and release HBGF-HSPG complexes locally to
effect AChR clustering. Indeed, a breakdown of HSPG
during early stages of synaptogenesis in Xenopus has
been suggested by a previous study (Anderson, 1986).
The role of tyrosine phosphorylation
The cytoplasmic domain of the bFGF receptor contains
a tyrosine kinase sequence (Pasquale and Singer, 1989;
Johnson et al. 1990; Musci et al. 1990). The binding of
bFGF to its receptor activates this kinase, which
undergoes autophosphorylation and phosphorylates
other substrate proteins on tyrosine residues. Pre-
viously we showed that a tyrosine kinase inhibitor
abolishes the formation of AChR clusters induced by
bFGF-coated beads (Peng et al. 1991). This result
suggests the essential role of tyrosine phosphorylation
in AChR clustering. The current study has shown that
the same inhibitor also blocks the clustering effect of
uncoated beads. The substrates for tyrosine phos-
phorylation responsible for AChR clustering are not
known. Qu et al. (1990) showed that fi, yand <5subunits
of the AChR undergo tyrosine phosphorylation during
synaptogenesis. However, this is seen after the AChRs
are already clustered. Recently, it has been shown that
agrin increases tyrosine phosphorylation of the
/3-subunit with a time course similar to AChR clustering
when applied to chick myotubes (Wallace et al. 1991).
Thus, tyrosine phosphorylation of both the AChR and
other proteins may be involved in cluster formation. In
addition to the autophosphorylation of the growth
factor receptor itself, phospholipase C-y is an early
substrate for a number of growth factor receptor-
associated tyrosine kinases, including the bFGF recep-
tor (Ullrich and Schlessinger, 1990; Burgess et al. 1990).
A recent study has shown that a consequence of
tyrosine phosphorylation of phospholipase C-y is a
release of the actin-binding protein profilin from its
phosphoinositide anchor in the plasma membrane
(Goldschmidt-Clermont et al. 1991). In addition, there
is mounting evidence for tyrosine phosphorylation of
other cytoskeletal proteins, e.g. spectrin and protein
4.1, by activated growth factor receptors (Subrahma-
nyam et al. 1991; Akiyama et al. 1986). Thus, tyrosine
kinase activity resulting from the activation of growth
factor receptors may lead to a reorganization of the
cytoskeleton. In fact, the assembly of an actin-based
cytoskeleton is one of the earliest events that can be
detected at sites of presumptive AChR clustering
induced by beads (Peng and Phelan, 1984; Rochlin et al.
1989). Our recent experiments have shown that an
accumulation of phosphotyrosine-containing proteins
at sites of bead-muscle contact can be detected within
15 min of the bead addition and these become foci of
AChR clustering during later stages (Baker and Peng,
1991). Thus, localized tyrosine phosphorylation stimu-
lated by a synaptogenic signal may play a pivotal role in
the formation of the postsynaptic specialization. The
local presentation and subsequent intracellular amplifi-
cation of this signal may be involved in the activation of
postsynaptic development.
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